Transdermal Delivery of AT1 Receptor Antagonists Reduce Blood Pressure and Reveal a Vasodilatory Effect on Kidney Blood Vessels

Download
[thumbnail of Ep37544_Patchpaper_CMP_Final.pdf]
Preview
Ep37544_Patchpaper_CMP_Final.pdf - Accepted Version (606kB) | Preview
Available under license: Creative Commons Attribution Non-commercial
Export

Michalatou, M, Androutsou, ME, Antonopoulos, M, Vlahakos, DV, Agelis, G, Zulli, Anthony ORCID: 0000-0002-2660-078X, Qaradakhi, T, Mikkelsen, Kathleen ORCID: 0000-0001-9166-4109, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Matsoukas, J (2018) Transdermal Delivery of AT1 Receptor Antagonists Reduce Blood Pressure and Reveal a Vasodilatory Effect on Kidney Blood Vessels. Current Molecular Pharmacology, 11 (3). 226 - 236. ISSN 1874-4672

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/37544
DOI 10.2174/1874467211666180419152036
Official URL http://www.eurekaselect.com/161423/article
Subjects Historical > FOR Classification > 1115 Pharmacology and Pharmaceutical Sciences
Historical > FOR Classification > 1116 Medical Physiology
Historical > Faculty/School/Research Centre/Department > Institute of Sport, Exercise and Active Living (ISEAL)
Keywords angiotensin receptor blockers; ARBs; Renin Angiotensin System; RAS; antihypertensive therapy; AT1; transdermal delivery
Citations in Scopus 2 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login

CORE (COnnecting REpositories)